Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
60 results (top 60)
- 1/2상모집 중· Arthritis, Rheumatoid난치성 류마티스 관절염 환자를 대상으로 한 BMS-986528 연구
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
리드: BMS
- 4상모집 중· Healthy Volunteers건강한 지원자에서 제토제 투여 시 카르엑스티의 안전성과 내약성을 평가하는 연구
Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers
협력: BMS
- 2상모집 중· Locally Advanced Non-Small Cell Lung Cancer (NSCLC)국소 진행성/전이성 비소세포 폐암의 1차 치료: 임조키투그 병용 요법의 안전성, 내약성 및 유효성 평가
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
리드: BMS
- 3상모집 중· Schizophrenia정신분열병 환자의 KarXT 치료에서의 재발 예방 임상시험
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
협력: BMS
- 2상모집 중· Solid Tumors동형 MTAP 결손이 있는 진행성 및/또는 전이성 고형종양 환자에서 BMS-986504 단일 요법 및 병용 요법 연구(MountainTAP-5)
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
리드: BMS
- 1상모집 중· Healthy Volunteers건강한 사람에서 BMS-986533의 안전성, 약동학, 음식·pH 효과 및 약물상호작용 평가 연구
Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants
리드: BMS
- 1/2상모집 중· SCHIZOPHRENIA 1 (Disorder)조현병에서 코벤피의 도파민 전달에 대한 PET/MRI 연구
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
협력: BMS
- 2상모집 중· Post-Stroke Spasticity뇌졸중 후 경직 환자에서 BMS-986368(FAAH/MAGL 억제제)의 효능, 안전성 및 내약성 평가 파일럿 연구(STIPS 연구)
A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)
협력: BMS
- 단계 미표기모집 중· β-thalassemia중동 지역의 수혈 의존성 베타 지중해빈혈 성인 환자에서 루스파테르셉트를 평가하는 실제 임상 연구
A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East
리드: BMS
- 1상모집 중· Healthy Volunteers건강한 성인 참가자에서 BMS-986521에 의한 M4 무스카린 아세틸콜린 수용체 점유도 평가를 위한 양전자방출단층촬영 연구
A Positron Emission Tomography Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants
리드: BMS
- 단계 미표기모집 중· Multiple Sclerosis다발성경화증 환자에서 제포시아 노출로 인한 진행성 다초점 백질뇌병증의 위험성
Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia
리드: BMS
- 2상모집 중· Central Centrifugal Cicatricial Alopecia반흔성 탈모증의 치료에서의 듀크라바시티닙
Deucravacitinib in the Treatment of Cicatricial Alopecias
협력: BMS
- 단계 미표기모집 중· Ulcerative ColitisA Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
리드: BMS
- 1상모집 중· Colorectal CancerA Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
협력: BMS
- 2상모집 중· Phase 2 StudyA Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
협력: BMS
- 1상모집 중· Diffuse Pleural MesotheliomaA Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
협력: BMS
- 1/2상모집 중· Advanced Renal Cell Carcinoma (RCC)A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
리드: BMS · 협력: 바이오엔테크
- 단계 미표기모집 중· Non Small Cell Lung Cancer NSCLCA Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)
협력: BMS
- 1/2상모집 중· Hepatocellular Carcinoma (HCC)A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
리드: BMS · 협력: 바이오엔테크
- 3상모집 중· Non-small Cell Lung Cancer (NSCLC)A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
리드: BMS · 협력: 바이오엔테크
- 2/3상모집 중· Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
리드: BMS · 협력: 바이오엔테크
- 단계 미표기모집 중· Lung Non-Small Cell CarcinomaExperiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study
협력: BMS
- 3상모집 중· Non-Small Cell Lung Cancer (NSCLC)A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
리드: BMS · 협력: 바이오엔테크
- 단계 미표기모집 중· Unresectable Hepatocellular CarcinomaFirst-Line Nivolumab Plus Ipilimumab in Unresectable Hepatocellular Carcinoma (J-PROMISE)
리드: BMS
- 1상모집 중· Rheumatoid ArthritisA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
리드: BMS
- 단계 미표기모집 중· SchizophreniaEffectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
리드: BMS
- 2상모집 중· Cutaneous MelanomaNeo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)
협력: BMS
- 1/2상모집 중· Relapsed/Refractory Small Cell Lung CancerA Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
리드: BMS
- 단계 미표기모집 중· Ulcerative Colitis (UC)Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
리드: BMS
- 1상모집 중· Renal Cell CarcinomaA First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
리드: BMS
- 단계 미표기모집 중· Obstructive Hypertrophic Cardiomyopathy (oHCM)Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US
리드: BMS
- 2상모집 중· Recurrent GlioblastomaA Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
리드: 바이오엔테크 · 협력: BMS
- 단계 미표기모집 중· Hypertrophic CardiomyopathyA Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
리드: BMS
- 해당없음모집 중· Rheumatoid Arthritis (RAHealthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being
협력: BMS
- 2/3상모집 중· Metastatic Non-small Cell Lung Cancer With MTAP DeletionA Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
리드: BMS
- 2/3상모집 중· Untreated, Unresectable, or Metastatic Colorectal CancerA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
리드: BMS · 협력: 바이오엔테크
- 1상모집 중· Healthy VolunteersA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.
리드: BMS
- 2상모집 중· Pancreatic Ductal Adenocarcinoma (PDAC)A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
리드: 바이오엔테크 · 협력: BMS
- 단계 미표기모집 중· NTRK Fusion-positive Solid TumorsRepotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive Tumors in Japan
리드: BMS
- 3상모집 중· Breast NeoplasmsROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
리드: 바이오엔테크 · 협력: BMS
- 1상모집 중· Advanced Solid TumorsA Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors
리드: BMS
- 1/2상모집 중· Solid TumoursA Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
리드: BMS
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.